Trends in first-time hospitalization, management, and short-term mortality in acute myocardial infarction-related cardiogenic shock from 2005-2017: A nationwide cohort study.

[1]  N. Danchin,et al.  Trends in cardiogenic shock complicating acute myocardial infarction , 2020, European journal of heart failure.

[2]  E. Ohman,et al.  Management of cardiogenic shock complicating myocardial infarction: an update 2019. , 2019, European heart journal.

[3]  C. Hassager,et al.  Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort study , 2019, European journal of heart failure.

[4]  Sigrun Alba Johannesdottir Schmidt,et al.  The Danish health care system and epidemiological research: from health care contacts to database records , 2019, Clinical epidemiology.

[5]  C. Terkelsen,et al.  Rationale and design of DanGer shock: Danish-German cardiogenic shock trial. , 2019, American heart journal.

[6]  Ajay K. Jain,et al.  Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group , 2018, European heart journal. Acute cardiovascular care.

[7]  H. Thiele,et al.  Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. , 2018, The Cochrane database of systematic reviews.

[8]  Marco Valgimigli,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[9]  H. Wienbergen,et al.  Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry , 2018, Clinical Research in Cardiology.

[10]  J. Wald,et al.  Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States , 2018, Clinical Research in Cardiology.

[11]  H. Thiele,et al.  Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials , 2017, European heart journal.

[12]  D. Mcareavey,et al.  Advanced Percutaneous Mechanical Circulatory Support Devices for Cardiogenic Shock , 2017, Critical care medicine.

[13]  E. Ohman,et al.  Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association , 2017, Circulation.

[14]  E. Ohman,et al.  Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock. , 2017, The American journal of cardiology.

[15]  S. Blankenberg,et al.  Concomitant implantation of Impella® on top of veno‐arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock , 2017, European journal of heart failure.

[16]  H. Bøtker,et al.  Positive predictive value of cardiac examination, procedure and surgery codes in the Danish National Patient Registry: a population-based validation study , 2016, BMJ Open.

[17]  H. Bøtker,et al.  Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study , 2016, BMJ Open.

[18]  B. D. de Mol,et al.  Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis , 2016, Intensive Care Medicine.

[19]  D. McManus,et al.  Decade-Long Trends (2001–2011) in the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction , 2016, Circulation. Cardiovascular quality and outcomes.

[20]  H. Sørensen,et al.  Data Resource Profile: The Danish National Prescription Registry. , 2016 .

[21]  Sigrun Alba Johannesdottir Schmidt,et al.  The Danish National Patient Registry: a review of content, data quality, and research potential , 2015, Clinical epidemiology.

[22]  Monique L. Anderson,et al.  Association of Bystander and First-Responder Intervention With Survival After Out-of-Hospital Cardiac Arrest in North Carolina, 2010-2013. , 2015, JAMA.

[23]  E. Omerovic,et al.  17-year trends in incidence and prognosis of cardiogenic shock in patients with acute myocardial infarction in western Sweden. , 2015, International journal of cardiology.

[24]  H. Nielsen,et al.  Positive predictive value of International Classification of Diseases, 10th revision, diagnosis codes for cardiogenic, hypovolemic, and septic shock in the Danish National Patient Registry , 2015, BMC Medical Research Methodology.

[25]  Henrik Toft Sørensen,et al.  The Danish Civil Registration System as a tool in epidemiology , 2014, European Journal of Epidemiology.

[26]  D. Kolte,et al.  Trends in Incidence, Management, and Outcomes of Cardiogenic Shock Complicating ST‐Elevation Myocardial Infarction in the United States , 2014, Journal of the American Heart Association.

[27]  M. Nørgaard,et al.  Validity of the coding for intensive care admission, mechanical ventilation, and acute dialysis in the Danish National Patient Registry: a short report , 2013, Clinical epidemiology.

[28]  G. Schuler,et al.  Intraaortic balloon support for myocardial infarction with cardiogenic shock. , 2012, The New England journal of medicine.

[29]  J. Gore,et al.  Cardiogenic shock complicating acute coronary syndromes: insights from the Global Registry of Acute Coronary Events. , 2012, American heart journal.

[30]  Timothy L Lash,et al.  25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study , 2012, BMJ : British Medical Journal.

[31]  K. Helweg-larsen.  The Danish Register of Causes of Death , 2011, Scandinavian journal of public health.

[32]  Timothy L Lash,et al.  The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients , 2011, BMC medical research methodology.

[33]  J. Vincent,et al.  Comparison of dopamine and norepinephrine in the treatment of shock. , 2010, The New England journal of medicine.

[34]  J. Gore,et al.  Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction: A Population-Based Perspective , 2009, Circulation.

[35]  J. Hochman,et al.  Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. , 2005, JAMA.

[36]  Klaus Rasmussen,et al.  A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. , 2003, The New England journal of medicine.

[37]  L. Sleeper,et al.  Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry , 2003 .

[38]  H. White,et al.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.